D5-PHARMA
ActiveActs, filings and financial milestones
Deadline for the 2026 accounts:
2026
31-08
abbreviated format · 31 days late
2025
2024
31-12
Financial
Weakest financial yearnet -€65,894
The net result drops to -€65,894, the lowest from 2018 to 2025. It recovers the following year.
31-01
Gazette deed
Company renamed from PHARMACIE ROUFOSSE to D5-PHARMAChange of role: AGANJU HOLDING, from manager to director · Legal-form conversion · Capital conversion11 points ▸
Gazette deed
Company renamed from PHARMACIE ROUFOSSE to D5-PHARMA
Change of role: AGANJU HOLDING, from manager to director · Legal-form conversion · Capital conversion11 points ▸
- General meeting, 15-01-2024
- Legal-form conversion, “Société à responsabilité limitée” (deed in French)
- Capital conversion, “compte de capitaux propres statutairement indisponible” (deed in French)
- Capital conversion, “compte de capitaux propres « apports non appelés »” (deed in French)
- Reserve release, “inclut les éventuels versements futurs de la part non encore libérée du capital, suppression du compte et mise des fonds à disposition pour distribution” (deed in French)
- Name change, D5-PHARMA
- Amendment of the articles
- Capital
- Other provision, “établir et signer la coordination des statuts, conformément à la décision précédente, et assurer son dépôt au dossier de la société, mission au notaire” (deed in French)
- Director resignation, AGANJU HOLDING (manager)
- Director appointment, AGANJU HOLDING (director (not named in the articles))
2023
31-08
full format · 31 days late
24-01
Gazette deed
Appointment: AGANJU (managing director)Permanent representative: Hervé HAMIAFO · Resignation: Isabelle ROUFOSSE (director)4 points ▸
Gazette deed
Appointment: AGANJU (managing director)
Permanent representative: Hervé HAMIAFO · Resignation: Isabelle ROUFOSSE (director)4 points ▸
- General meeting, 11-01-2023
- Director appointment, AGANJU (managing director)
- Permanent representative, Hervé HAMIAFO
- Director resignation, Isabelle ROUFOSSE (director)
2022
07-07
full format · 24 days before the deadline
2021
31-12
Financial
Liquidity more than doubledcurrent ratio 5.46
The current ratio rises from 2.08 to 5.46. Short-term debt falls from €280,319 to €81,321.
20-07
full format · 11 days before the deadline
2020
31-12
Financial
Highest result from 2018 to 2025net €81,232 ▲66.7%
The operating result of €99,511 and the net result of €81,232 are both a record.
Show earlier events
16-10
full format · 77 days late
2019
30-08
full format · 30 days late
2018
30-08
full format · 30 days late
2017
19-07
full format · 12 days before the deadline
2003
07-03
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank